Drug Profile
NCX 1005
Latest Information Update: 31 Jul 2012
Price :
$50
*
At a glance
- Originator NicOx
- Class Anti-inflammatories; Antiasthmatics
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Inflammatory bowel diseases
Most Recent Events
- 27 Jul 2012 Discontinued - Preclinical for Asthma in Europe (unspecified route)
- 27 Jul 2012 Discontinued - Preclinical for Inflammatory bowel disease in Europe (unspecified route)
- 17 Jun 1999 Profile reviewed